Literature DB >> 20634924

Serum Neuregulin-1beta as a Biomarker of Cardiovascular Fitness.

Vaibhav Moondra1, Satyam Sarma, Tracy Buxton, Radwan Safa, Gregory Cote, Thomas Storer, Nathan K Lebrasseur, Douglas B Sawyer.   

Abstract

PURPOSE: Neuregulins (NRG) are growth factors that bind to receptors of the erbB family, and are known to mediate a number of processes involved in diverse tissues. Neuregulin-1beta is expressed in skeletal muscle and is activated by exercise. We hypothesized that NRG-1beta might circulate in the bloodstream and increase as a consequence of physical activity. A study was conducted in healthy subjects to determine if NRG-1beta is immunodetectable in human serum, and if so whether levels relate acutely or chronically to exercise.
METHODS: Nine healthy men underwent three bouts of exercise of varying degrees of intensity on a bicycle ergometer over a period of three weeks. Cardio-respiratory fitness was determined by measurement of maximal oxygen uptake (VO(2)max). Serum was sampled prior to and immediately after each session (up to 30 minutes post) and serum NRG-1beta was quantified utilizing an indirect sandwich ELISA assay developed in our lab.
RESULTS: Across subjects, mean serum NRG-1beta levels ranged from 32 ng/mL to 473 ng/mL. Individual subjects showed relatively stable levels during the study period that did not change acutely after exercise. Serum NRG-1beta demonstrated a positive correlation with VO(2)max (r2=0.49, p =.044).
CONCLUSIONS: These preliminary observations suggest that at least in healthy men, serum NRG-1beta is an indicator of cardio-respiratory fitness and does not change acutely with exercise.

Entities:  

Year:  2009        PMID: 20634924      PMCID: PMC2903891          DOI: 10.2174/1875318300902010001

Source DB:  PubMed          Journal:  Open Biomark J


  21 in total

1.  A novel role of neuregulin in skeletal muscle. Neuregulin stimulates glucose uptake, glucose transporter translocation, and transporter expression in muscle cells.

Authors:  E Suárez; D Bach; J Cadefau; M Palacin; A Zorzano; A Gumá
Journal:  J Biol Chem       Date:  2001-03-16       Impact factor: 5.157

2.  Neuregulin stimulates myogenic differentiation in an autocrine manner.

Authors:  D Kim; S Chi; K H Lee; S Rhee; Y K Kwon; C H Chung; H Kwon; M S Kang
Journal:  J Biol Chem       Date:  1999-05-28       Impact factor: 5.157

3.  Neuregulin-1alpha and beta isoform expression in cardiac microvascular endothelial cells and function in cardiac myocytes in vitro.

Authors:  Gregory M Cote; Thomas A Miller; Nathan K Lebrasseur; Yukio Kuramochi; Douglas B Sawyer
Journal:  Exp Cell Res       Date:  2005-09-26       Impact factor: 3.905

4.  Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy.

Authors:  Xifu Liu; Xinhua Gu; Zhaoming Li; Xinyan Li; Hui Li; Jianjie Chang; Ping Chen; Jing Jin; Bing Xi; Denghong Chen; Donna Lai; Robert M Graham; Mingdong Zhou
Journal:  J Am Coll Cardiol       Date:  2006-09-14       Impact factor: 24.094

5.  The expression of neuregulin and erbB receptors in human skeletal muscle: effects of progressive resistance training.

Authors:  Nathan K LeBrasseur; Kelly C Mizer; Jascha D Parkington; Douglas B Sawyer; Roger A Fielding
Journal:  Eur J Appl Physiol       Date:  2005-05-04       Impact factor: 3.078

6.  The serum levels of growth factors: PDGF, TGF-beta and VEGF are increased after strenuous physical exercise.

Authors:  B Czarkowska-Paczek; I Bartlomiejczyk; J Przybylski
Journal:  J Physiol Pharmacol       Date:  2006-06       Impact factor: 3.011

7.  Acetylcholine receptor-inducing activity stimulates expression of the epsilon-subunit gene of the muscle acetylcholine receptor.

Authors:  J C Martinou; D L Falls; G D Fischbach; J P Merlie
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

8.  ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family.

Authors:  D L Falls; K M Rosen; G Corfas; W S Lane; G D Fischbach
Journal:  Cell       Date:  1993-03-12       Impact factor: 41.582

9.  Neuregulins regulate cardiac parasympathetic activity: muscarinic modulation of beta-adrenergic activity in myocytes from mice with neuregulin-1 gene deletion.

Authors:  Katashi Okoshi; Masaharu Nakayama; Xinhua Yan; Marina P Okoshi; Adam J T Schuldt; Mark A Marchionni; Beverly H Lorell
Journal:  Circulation       Date:  2004-08-02       Impact factor: 29.690

10.  Heregulin ameliorates the dystrophic phenotype in mdx mice.

Authors:  Thomas O B Krag; Sasha Bogdanovich; Claus J Jensen; M Dominik Fischer; Jacob Hansen-Schwartz; Elisabeth H Javazon; Alan W Flake; Lars Edvinsson; Tejvir S Khurana
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-13       Impact factor: 11.205

View more
  14 in total

Review 1.  Neuregulin-1 signaling in the pathogenesis of chemotherapy-induced heart failure.

Authors:  Carrie Geisberg Lenneman
Journal:  Curr Heart Fail Rep       Date:  2014-06

2.  Neuregulin-1β regulation of embryonic endothelial progenitor cell survival.

Authors:  Radwan N Safa; Xu-Yang Peng; Laura Pentassuglia; Chee Chew Lim; Mathias Lamparter; Cheri Silverstein; Jeremy Walker; Billy Chen; Carrie Geisberg; Antonis K Hatzopoulos; Douglas B Sawyer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-01-14       Impact factor: 4.733

3.  Exercise training and return to a well-balanced diet activate the neuregulin 1/ErbB pathway in skeletal muscle of obese rats.

Authors:  Gaël Ennequin; Nathalie Boisseau; Kevin Caillaud; Vivien Chavanelle; Maude Gerbaix; Lore Metz; Monique Etienne; Stéphane Walrand; Aurélie Masgrau; Christelle Guillet; Daniel Courteix; Airu Niu; Yi-Ping Li; Fréderic Capel; Pascal Sirvent
Journal:  J Physiol       Date:  2015-05-14       Impact factor: 5.182

4.  Neuregulin1-β decreases interleukin-1β-induced RhoA activation, myosin light chain phosphorylation, and endothelial hyperpermeability.

Authors:  Limin Wu; Servio H Ramirez; Allison M Andrews; Wendy Leung; Kanako Itoh; Jiang Wu; Ken Arai; Eng H Lo; Josephine Lok
Journal:  J Neurochem       Date:  2015-11-10       Impact factor: 5.372

Review 5.  Neuregulin-1β for the treatment of systolic heart failure.

Authors:  Douglas B Sawyer; Anthony Caggiano
Journal:  J Mol Cell Cardiol       Date:  2011-06-28       Impact factor: 5.000

6.  Circulating neuregulin-1β levels vary according to the angiographic severity of coronary artery disease and ischemia.

Authors:  Carrie Anna Geisberg; Guisong Wang; Radwan N Safa; Holly M Smith; Brent Anderson; Xu-Yang Peng; Brian Veerkamp; David X Zhao; Dana Blakemore; Chang Yu; Douglas B Sawyer
Journal:  Coron Artery Dis       Date:  2011-12       Impact factor: 1.439

Review 7.  Neuregulin as a heart failure therapy and mediator of reverse remodeling.

Authors:  Cristi L Galindo; Sergey Ryzhov; Douglas B Sawyer
Journal:  Curr Heart Fail Rep       Date:  2014-03

Review 8.  Neuregulin in cardiovascular development and disease.

Authors:  Oghenerukevwe Odiete; Michael F Hill; Douglas B Sawyer
Journal:  Circ Res       Date:  2012-10-26       Impact factor: 17.367

Review 9.  Cancer therapy-induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies.

Authors:  Virginia Shalkey Hahn; Daniel J Lenihan; Bonnie Ky
Journal:  J Am Heart Assoc       Date:  2014-04-22       Impact factor: 5.501

10.  Neuregulin-1 Administration Protocols Sufficient for Stimulating Cardiac Regeneration in Young Mice Do Not Induce Somatic, Organ, or Neoplastic Growth.

Authors:  Balakrishnan Ganapathy; Nikitha Nandhagopal; Brian D Polizzotti; David Bennett; Alparslan Asan; Yijen Wu; Bernhard Kühn
Journal:  PLoS One       Date:  2016-05-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.